<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Dsm-Firmenich on Bioecon</title><link>https://en.bioecon.ru/companies/dsm-firmenich/</link><description>Recent content in Dsm-Firmenich on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 27 Jul 2026 12:30:47 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/dsm-firmenich/index.xml" rel="self" type="application/rss+xml"/><item><title>Biosynthetic theobromine</title><link>https://en.bioecon.ru/technology/biosynthetic-theobromine/</link><pubDate>Sun, 26 Jul 2026 22:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-theobromine/</guid><description>Theobromine (3,7-dimethylxanthine) — cocoa&amp;rsquo;s signature xanthine alkaloid — is sourced today from cocoa-processing byproducts (Cargill) and methylxanthine API manufacturing (Bajaj Healthcare, CSPC Innovation Pharma), while precision-fermentation and deforestation-free molecular synthesis (DSM-Firmenich, Fermtech) emerge under EU Deforestation Regulation pressure; this article covers the pure molecule, distinct from cocoa-free chocolate alternatives.</description></item><item><title>Biosynthetic capsaicin</title><link>https://en.bioecon.ru/technology/biosynthetic-capsaicin/</link><pubDate>Sun, 26 Jul 2026 21:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-capsaicin/</guid><description>Capsaicin — the pungent capsaicinoid of Capsicum peppers — is at the intersection of plant-cell biotechnology (Debut&amp;rsquo;s cultivation-free fermentation), precision-fermentation flavour modulation (DSM-Firmenich, Givaudan) and a centuries-old capsicum-oleoresin extraction base anchored in India by Plant Lipids; fermentation-route biosynthesis remains emerging while extraction still dominates global supply.</description></item><item><title>Biosynthetic musk &amp; aromas</title><link>https://en.bioecon.ru/technology/biosynthetic-musk-aromas/</link><pubDate>Tue, 21 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-musk-aromas/</guid><description>The confirmed 2026 commercial market for non-animal musk is dominated by established macrocyclic ketone/lactone brands — Givaudan&amp;rsquo;s Velvione (a 16-membered macrocyclic musk ketone) and DSM-Firmenich&amp;rsquo;s Exaltolide — plus IFF&amp;rsquo;s newly launched Orionide Oliffac clean-musk line (unveiled at SIMPPAR 2026) and, in China, Beijing Lianxin Pharmaceutical&amp;rsquo;s state-designated Class-1 artificial-musk substitute for traditional-medicine use (founded 1999, National S&amp;amp;T Progress Award), while the engineered-yeast fermentation route described in early research (omega-oxidation, lipase-catalyzed macrocyclization) remains at the patent-application stage with no confirmed commercial fermentation-musk originator.</description></item><item><title>Microalgal omega-3 (EPA/DHA algal oils)</title><link>https://en.bioecon.ru/technology/microalgal-omega-3/</link><pubDate>Thu, 09 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/microalgal-omega-3/</guid><description>Microalgae-derived EPA and DHA omega-3 oils — from Crypthecodinium, Nannochloropsis and Schizochytrium — produced as vegan nutraceutical and infant-nutrition ingredients by DSM-Firmenich, Qualitas Health, Fermentalg and Kingdomway.</description></item><item><title>Bio-deactivation of anti-nutritional factors</title><link>https://en.bioecon.ru/technology/bio-deactivation-anti-nutritional-factors/</link><pubDate>Tue, 07 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bio-deactivation-anti-nutritional-factors/</guid><description>Enzymes and controlled fermentation are neutralizing the phytate, trypsin inhibitors and oligosaccharides that limit nutrient uptake from plant-based feed — an EU-authorized next-generation phytase, a fermented-soy process cutting risk on batch-to-batch antinutrient variability, and a Chinese phytase producer trimming manure phosphorus by up to 60%.</description></item><item><title>Enzymatic therapy for celiac</title><link>https://en.bioecon.ru/technology/enzymatic-therapy-celiac/</link><pubDate>Tue, 07 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/enzymatic-therapy-celiac/</guid><description>Engineered enzymes and enzyme-target inhibitors are moving toward pharmaceutical protection from gluten exposure in celiac disease — a Barcelona-designed gastric enzyme validated in mouse models, a transglutaminase-2 inhibitor showing histologic protection in human trials, and a $35M Takeda-funded oral enzyme program whose later trial stage reportedly worsened mucosal damage.</description></item><item><title>Aquaculture microbiome management</title><link>https://en.bioecon.ru/technology/aquaculture-microbiome/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/aquaculture-microbiome/</guid><description>Multispecies probiotic blends and microencapsulated Bacillus/Streptomyces strains manage shrimp and fish gut and pond-water microbiomes, controlling Vibrio-driven disease without antibiotics.</description></item><item><title>Human milk oligosaccharides (HMOs)</title><link>https://en.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</guid><description>Precision-fermented human milk oligosaccharides — 2&amp;rsquo;-fucosyllactose, LNnT and sialylated sugars produced by engineered E. coli or yeast — that feed infant-formula bifidobacteria and block pathogen attachment, now expanding from infant nutrition into adult gut-health supplements.</description></item><item><title>Vitamins (D3, B-group, ascorbic acid)</title><link>https://en.bioecon.ru/technology/vitamins-d3-b-group-ascorbic-acid/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/vitamins-d3-b-group-ascorbic-acid/</guid><description>Industrial-scale vitamin manufacturing — B-group vitamins by direct fermentation, vitamin C by two-stage bioconversion of glucose, and vitamin D3 by UV photochemistry — concentrated overwhelmingly in China for bulk ascorbic acid while the EU retains unique fermentation capacity for riboflavin and stability-engineered feed premixes.</description></item><item><title>Microbiome cosmetics (skin microbiome)</title><link>https://en.bioecon.ru/technology/microbiome-cosmetics/</link><pubDate>Thu, 02 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/microbiome-cosmetics/</guid><description>Cosmetic bio-actives — prebiotics, postbiotics and bacterial lysates — and biome-friendly bases that nourish the skin&amp;rsquo;s commensal flora (not live drugs): a fast-growing clean-beauty segment built on 16S rRNA profiling and selective preservation.</description></item><item><title>Methane reduction in ruminants</title><link>https://en.bioecon.ru/technology/methane-reduction-ruminants/</link><pubDate>Wed, 01 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/methane-reduction-ruminants/</guid><description>Feed additives, red-seaweed and vaccine technologies that suppress enteric methanogenesis in cattle, sheep and goats — delivering 30–98% methane reduction while recovering 3–7% of feed energy as propionate.</description></item><item><title>Alternative honey &amp; biosynthetic honey</title><link>https://en.bioecon.ru/technology/alternative-honey-biosynthetic-honey/</link><pubDate>Sun, 28 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/alternative-honey-biosynthetic-honey/</guid><description>Bee-free honey produced ex vivo by precision fermentation: recombinant bee enzymes (invertase, glucose oxidase) expressed in Pichia pastoris convert a blended plant-sugar and phytochemical base into a vegan, hypoallergenic honey chemically identical to the natural product.</description></item><item><title>Metabolic engineering</title><link>https://en.bioecon.ru/technology/metabolic-engineering/</link><pubDate>Thu, 25 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/metabolic-engineering/</guid><description>Rational design and optimization of microbial metabolic pathways to produce high-value chemicals, advanced materials, and alternative proteins at industrial scale.</description></item><item><title>Biosynthetic specialty &amp; fine chemicals (precision fermentation, biocatalysis, biorefinery)</title><link>https://en.bioecon.ru/technology/biosynthetic-specialty-chemicals/</link><pubDate>Mon, 22 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-specialty-chemicals/</guid><description>High-value molecules — flavors, fragrances, food ingredients and bio-based monomers — produced by precision fermentation, biocatalysis and lignocellulose biorefinery from renewable carbon instead of petrochemicals or extraction.</description></item></channel></rss>